RxDoctor Payments Data

Robert Cox, MD

Family Medicine · Greenville, NCNPI 1164480026

Payments from drug & device makers

$1,675in general payments, 2019–2025

Across 129 payments — averaging $12.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$354
  • Amgen$339
  • Merck$155
  • AstraZeneca$152
  • Teva Pharmaceuticals USA, Inc.$145
  • Astellas Pharma US Inc$112
  • plus $418 from 13 others

What the payments were for

  • Food & beverage$1,675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,675 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$486,886
Medicare patients
625
Services billed
24,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$98,743
XareltoRivaroxaban62$52,128
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$43,788
Repatha SureclickEvolocumab58$34,869
JardianceEmpagliflozin42$33,304
JanuviaSitagliptin Phosphate31$33,011
FarxigaDapagliflozin Propanediol34$27,486
OzempicSemaglutide32$27,095
JanumetSitagliptin Phos/Metformin Hcl30$20,507
MounjaroTirzepatide20$20,428
LinzessLinaclotide13$17,476
MyrbetriqMirabegron26$16,961
Breo ElliptaFluticasone/Vilanterol25$13,399
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$12,998
Bydureon BciseExenatide Microspheres13$9,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$48$104,460164 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Shingrix$14$66,692120 claims
MerckJanuvia, Janumet$155$53,51861 claims
AstraZenecaFarxiga, Breztri Aerosphere$152$40,48455 claims
Novo NordiskOzempic$354$27,09532 claims
AbbVieLinzess, Synthroid$32$20,79359 claims
Lilly USA, LLCMounjaro$50$20,42820 claims
Astellas Pharma US IncMyrbetriq$112$16,96126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →